- Home
- BAH vs BMRN Comparison
BAH vs BMRN Comparison
Compare BAH & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAH
- BMRN
- Stock Information
- Founded
- BAH 1914
- BMRN 1996
- Country
- BAH United States
- BMRN United States
- Employees
- BAH N/A
- BMRN N/A
- Industry
- BAH Professional Services
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- BAH Consumer Discretionary
- BMRN Health Care
- Exchange
- BAH Nasdaq
- BMRN Nasdaq
- Market Cap
- BAH 17.0B
- BMRN 13.7B
- IPO Year
- BAH 2010
- BMRN 1999
- Fundamental
- Price
- BAH $113.68
- BMRN $59.17
- Analyst Decision
- BAH Buy
- BMRN Buy
- Analyst Count
- BAH 12
- BMRN 22
- Target Price
- BAH $147.36
- BMRN $94.00
- AVG Volume (30 Days)
- BAH 3.0M
- BMRN 2.0M
- Earning Date
- BAH 05-23-2025
- BMRN 05-01-2025
- Dividend Yield
- BAH 1.94%
- BMRN N/A
- EPS Growth
- BAH 116.72
- BMRN 153.71
- EPS
- BAH 6.70
- BMRN 2.21
- Revenue
- BAH $11,776,700,000.00
- BMRN $2,853,915,000.00
- Revenue This Year
- BAH $14.03
- BMRN $12.23
- Revenue Next Year
- BAH $7.16
- BMRN $9.93
- P/E Ratio
- BAH $16.98
- BMRN $26.81
- Revenue Growth
- BAH 14.07
- BMRN 17.97
- 52 Week Low
- BAH $101.05
- BMRN $52.93
- 52 Week High
- BAH $190.59
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- BAH 56.66
- BMRN 37.64
- Support Level
- BAH $103.22
- BMRN $52.93
- Resistance Level
- BAH $113.13
- BMRN $60.93
- Average True Range (ATR)
- BAH 5.72
- BMRN 3.18
- MACD
- BAH 0.94
- BMRN -0.53
- Stochastic Oscillator
- BAH 84.37
- BMRN 34.01
About BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.